Kida et al. described these two major subclones of MDS-L and demonstrated that MDS-L-2007 proliferated in response to high dose (100 ng/mL) IL-3 while the MDS-LGF proliferated in response to much lower doses (1ng/mL). This evidence concerns the gene IL3 and myelodysplastic syndrome.